A Robust Method for the Large-Scale Production of Spheroids for High-Content Screening and Analysis Applications

Summary

This protocol details a method for the production of three different types of spheroids in a manner that makes them suitable for large-scale high-content screening and analysis. In addition, examples are presented showing how they can be analyzed at spheroid and individual cell levels.

Abstract

High-content screening (HCS) and high-content analysis (HCA) are technologies that provide researchers with the ability to extract large-scale quantitative phenotypic measurements from cells. This approach has proved powerful for deepening our understanding of a wide range of both fundamental and applied events in cell biology. To date, the majority of applications for this technology have relied on the use of cells grown in monolayers, although it is increasingly realized that such models do not recapitulate many of the interactions and processes that occur in tissues. As such, there has been an emergence in the development and use of 3-dimensional (3D) cell assemblies, such as spheroids and organoids. Although these 3D models are particularly powerful in the context of cancer biology and drug delivery studies, their production and analysis in a reproducible manner suitable for HCS and HCA present a number of challenges. The protocol detailed here describes a method for the generation of multicellular tumor spheroids (MCTS), and demonstrates that it can be applied to three different cell lines in a manner that is compatible with HCS and HCA. The method facilitates the production of several hundred spheroids per well, providing the specific advantage that when used in a screening regime, data can be obtained from several hundred structures per well, all treated in an identical manner. Examples are also provided, which detail how to process the spheroids for high-resolution fluorescence imaging and how HCA can extract quantitative features at both the spheroid level as well as from individual cells within each spheroid. This protocol could easily be applied to answer a wide range of important questions in cell biology.

Introduction

Traditionally, cell-based assays have been performed in monolayers growing on a solid substrate, which effectively can be considered as a two-dimensional (2D) environment. However, it is becoming increasingly recognized that 2D cell culture models lack physiological relevance in some contexts and cannot replicate many of the complex interactions that occur between cells¹. Three-dimensional (3D) cell culture methods are rapidly becoming popular among researchers, and 3D cell models show high potential to better mimic the physiological conditions encountered by cells in the tissue environment². There are several different types of 3D cell assemblies that have been employed, but the two most common types are spheroids and organoids. Spheroids can be grown from many different cell lines, and they can adopt various shapes and sizes depending on the cell type used and their method of assembly³. Moreover, spheroids can also be referred to as multicellular tumor spheroids (MCTS) when they are grown from cancer cell lines, and these models have found particular use for preclinical in vitro drug delivery and toxicity studies^4,5. Organoids, on the other hand, aim to better mimic the tissues and organs in our body and can adopt more complex morphological arrangements. The production of organoids involves the use of adult stem cells or pluripotent stem cells, which can be reprogrammed into the appropriate cells to resemble the tissue or organ of interest. They are primarily used to investigate the development of organs and to model diseases and host-pathogen interactions⁶.

There is a range of different methods used to generate 3D cell assemblies. Scaffold-based methods provide a substrate or support to which cells can either attach or grow within. These scaffolds can have various shapes and can be made from a variety of different materials. The most common are extracellular matrix (ECM) components and hydrogels, and they are designed to resemble the natural extracellular environment of cells and thereby facilitate physiological interactions^4,7. ECM basement material has been extracted from Engelbreth-Holm-Swarm mouse sarcoma tumor and shown to contain a rich mixture of ECM components, including laminin, type IV collagen, and perlecan⁸. However, despite its advantageous composition, there are two main challenges with its use, namely its batch-to-batch variability and that it has two different aggregate states below and above 10 °C^8,9. In contrast, hydrogels have the advantage of being flexible with respect to their components and rigidity, and they can be customized to suit the specific 3D cell assembly desired^7,10. Scaffold-based methods are essential for organoid growth but are also widely used for spheroids. Scaffold-free methods, which work by preventing cells from attaching to the surface they are growing on, are usually only compatible with spheroid assembly. Examples include ultra-low attachment (ULA) plates, with either a flat bottom or U-bottom, which allow aggregation of the cells into spheroids, or the use of continuous agitation of the cells in spinner/rotation flasks¹⁰.

The use of 3D cell assemblies to study a wide variety of biological events is rapidly gaining popularity; however, it is essential that the method chosen for their culture is appropriate and compatible with the plans for their downstream analysis. For example, the use of ULA plates generates spheroids of high consistency; however, this method is restricted to the production of a single spheroid per well, thereby limiting throughput. Particular consideration is needed when fluorescence imaging of the 3D structure is planned. The substrate or plate on which the assembly is grown needs to be optically compatible, and care must be taken to minimize the effects of light scattering caused by any scaffolds that may have been used¹¹. This particular problem becomes more acute as the numerical aperture of the microscope objective lenses increases.

Arguably one of the major reasons for selecting to work with a 3D cell model is to extract volumetric imaging data about not only the entire assembly but also the individual cells within it. MCTS models, in particular, are beginning to prove very powerful for deepening our understanding of how therapeutics transit from the outside to central cells (as they would need to in a tumor)¹², and so gaining knowledge from individual cells at different layers is essential. The imaging technology that extracts quantitative information from individual cells is termed high-content analysis (HCA) and is a powerful approach in the context of screening¹³. To date, HCA has almost exclusively been applied to monolayer cultures, but there is an increasing realization that this approach has the power to be applied to 3D cultures enabling a wide range of cellular functions and processes to be studied¹⁴. It would have the clear advantage that large numbers of 3D assemblies could be analyzed, potentially providing cell-level data from across each structure. However, challenges associated with imaging of potentially thick cell assemblies, as well as the large data sets generated, need to be overcome.

In this article, a robust scaffold-based method for the large-scale production of MCTS in a 96-well format is presented. The method facilitates the production of several hundred 3D cell assemblies in each well. Examples are shown for three different cell types, representing solid tumor models of the liver, lung, and colon. The spheroids that form can be of a variety of sizes, and so HCA is used to select structures of a particular size and/or morphology. This feature provides the additional advantage that any phenotypes observed can be compared across spheroids of different sizes, but all treated in the same way in the same well. This approach is compatible with high-resolution imaging, importantly providing both cell-level and subcellular level quantitative data from the same cellular assemblies. This method of spheroid production has the additional advantage over methods that generate a single spheroid per well, that the large numbers of spheroids produced in each well potentially provide sufficient biomass for other downstream analyses, such as transcriptome and proteome profiling.

Protocol

1. Cell culture

1. Prepare media
   1. Prepare specific cell culture media depending on the type of cell line. Ensure that all media for cell maintenance contains 10% Foetal Bovine Serum (FBS).
      NOTE: Different cell lines use different media. HT-29 colon carcinoma cells (ATCC HTB-38) are grown in McCoys 5A + 10% FBS. HepG2 hepatocellular carcinoma cells (ATCC HB-8065) are grown in Minimum Essential Medium + 1% L-glutamine + 10% FBS. H358 bronchoalveolar carcinoma cells (ATCC CRL-5807) are grown in RPMI 1640 medium + 1% L-glutamine + 10% FBS. All media containing L-glutamine and FBS are referred to as complete media. When plating cells to grow as spheroids, a phenol red-free medium with 10% FBS is required to avoid coloring of the ECM basement material, which in turn can cause artifacts during the imaging process.
2. Subculture cells
   1. When cells are approximately 80% confluent, wash briefly with 2 mL of trypsin-EDTA (0.25% (w/v) trypsin/0.53 mM EDTA). Aspirate the trypsin-EDTA, add 3 mL of fresh trypsin-EDTA and incubate for 3-5 min at 37 °C.
   2. When cells are detached from the cell culture dish, add 7 mL of fresh complete medium.
   3. Pipette 1 mL of cell suspension into a new 10 cm cell culture dish and add 9 mL of fresh complete medium to give a 1:10 dilution of cells.
   4. Culture the cells at 37 °C in a humidified incubator with 5% CO₂.
   5. Subculture the cells every 3-5 days, depending on the cell line.

2. Generation of spheroids

1. Coat 96-well plates with ECM basement material
   1. Thaw ECM basement material on ice overnight.
   2. Dilute ECM basement material in cold phenol red-free serum-free medium using pre-chilled tips kept at -20 °C.
      NOTE: The final concentration of ECM basement material depends on the cell line used. For HT-29 and H358 cells, use 4 mg·mL^-1 of ECM basement material. For HepG2 cells, use 4 mg·mL^-1 of reduced growth factor ECM basement material.
   3. Pipette 15 µL of the ECM basement material/medium solution into a 96-well imaging plate.
      NOTE: For large-scale spheroid production, this step can be performed with both an 8-channel pipette and a 96-channel pipetting head, as long as the tips and reservoir containing the ECM basement material are chilled.
   4. Centrifuge the plate for 20 min at 91 x g at 4 °C.
   5. Incubate the plate for no longer than 30 min at 37 °C.
2. Subculture and count cells
   1. During the plate incubation period, incubate the cells with trypsin-EDTA and resuspend them in a complete medium containing 10% FBS.
   2. Pipette 10 µL of the cell suspension into a hemocytometer counting chamber. Count the number of cells in 4 quadrants of the chamber.
   3. Calculate the number of cells within the cell suspension by determining the mean number of cells within the 4 quadrants.
      NOTE: Cells can also be counted using automated cell-counting devices.
   4. Centrifuge the cells at 135 x g for 4 min at room temperature (RT).
   5. Once the cells are pelleted, aspirate the supernatant and resuspend the cells in a phenol red-free complete medium to obtain a concentration of 1 x 10⁶ cells per mL.
3. Seed cells into ECM basement material-coated plates
   1. Dilute the cells in a phenol red-free complete medium.
      NOTE: The density of cells seeded is dependent on the cell line used. For HT-29 and HepG2 cells, 3 x 10⁴ cells are seeded per well; for H358 cells, 4 x 10⁴ cells are seeded per well.
   2. Seed the cells in a total volume of 35 µL per well. Ensure to add them dropwise in a circular motion.
      ​NOTE: For large-scale spheroid production, this step can be performed with an 8-channel pipette, as long as the pipetting circular motion can be achieved.
   3. Incubate the cells for 1 h at 37 °C in a humidified incubator with 5% CO₂.
   4. Prepare a solution of ECM basement material in phenol red-free complete medium, which results in a final concentration of 2% ECM basement material in the well. To achieve this, add 1.2 µL of ECM basement material to 23.8 µL of phenol red-free complete medium per well, resulting in a final volume of 60 µL per well.
   5. Incubate the cells at 37 °C in a humidified incubator with 5% CO₂.
   6. The following day, replace the medium with 100 µL of fresh phenol red-free complete medium.
   7. Replace the medium every second day with 100 µL of fresh phenol red-free complete medium.

3. Immunofluorescence staining of spheroids

NOTE: This protocol is adapted from Nürnberg et al., 2020¹⁵. These adaptations are primarily based on the fact that the spheroids described in this protocol are smaller than those used in the Nürnberg et al. work¹⁵ and, as such, facilitate shorter incubation times. For example, blocking times are reduced from 2 h to 1 h. In addition, as the protocol is designed for high-throughput production of spheroids, all of the processing steps are carried out in the well in which the spheroids are cultured, meaning that transfer of individual spheroids into tubes is not required.

1. Prepare all solutions and buffers required for fixing and staining
   1. Prepare Phosphate Buffered Saline (PBS) by adding 1 PBS tablet per 200 mL of water. Autoclave the PBS.
   2. Prepare paraformaldehyde (PFA) following steps 3.1.3-3.1.4.
   3. Use a heated stirrer to heat 400 mL of PBS to 60-70 °C in a fume hood. Add 15 g of PFA while stirring. Once the PFA has dissolved, add 50 µL of 1 M CaCl₂ and 50 µL of 1 M MgCl₂.
   4. Add 100 mL of PBS to make a final volume of 500 mL. Use NaOH to equilibrate the PFA to pH 7.4. Filter the PFA through sterile vacuum filters (pore size 0.22 µm), aliquot, and store at -20 °C.
   5. Prepare a 1 M glycine stock solution by adding 3.75 g of glycine to 50 mL of PBS. Store at 4 °C.
   6. Prepare 5 mL of permeabilization buffer by adding 100 µL of Triton X-100, 1 mL of dimethyl sulfoxide (DMSO) and 1.5 mL of 1 M glycine to 2.4 mL of PBS. Store at 4 °C for no longer than 2 weeks.
   7. Prepare 5 mL of blocking buffer by adding 100 µL of Triton X-100, 0.5 mL of DMSO and 0.05 g of bovine serum albumin (BSA) to 4.9 mL of PBS. Aliquot the blocking buffer into 1.5 mL tubes and store at -20 °C.
   8. Prepare 5 mL of antibody incubation buffer by adding 10 µL of polysorbate 20, 0.05 g of BSA, and 250 µL of DMSO to 4.74 mL of PBS. Aliquot the antibody incubation buffer into 1.5 mL tubes and store it at -20 °C.
      NOTE: In the protocol described here, spheroids are only assembled in the inner 60 wells of a 96-well plate, although they can be prepared in all 96 wells of the plate. The reason for only preparing spheroids in the inner 60 wells is that some high numerical aperture objective lenses are not capable of physically being able to image the entire well of the outer wells due to the 'skirt' on some plate types. The above volumes are sufficient for the preparation of 60 wells containing spheroids.
2. Fix and permeabilize the spheroids
   1. Carefully remove the medium from the spheroids, ensuring that the ECM basement material layer is not disturbed.
   2. Wash the spheroids twice with 70 µL of PBS for 3 min each time.
   3. Fix the spheroids with 70 µL of 3% PFA for 1 h at 37 °C.
   4. Wash the spheroids twice with 70 µL of PBS for 3 min each time.
   5. Quench with 70 µL of 0.5 M glycine solution for 30 min at 37 °C.
   6. Permeabilize the spheroids using 70 µL of the permeabilization buffer for 30 min at RT.
   7. Wash the spheroids twice with 70 µL of PBS for 3 min each time.
   8. Incubate the spheroids in 70 µL of blocking buffer for 1 h at 37 °C.
      NOTE: Once the spheroids have been fixed, all subsequent processing steps can be performed using an 8-channel pipette, or a 96-well pipetting head, if available. This increases the speed of spheroid preparation prior to imaging.
3. Immunostain spheroids using primary and secondary antibodies
   1. Dilute the primary antibody to an appropriate dilution in the antibody incubation buffer and add 70 µL to each well. Incubate the spheroids with the primary antibody overnight.
      NOTE: The dilution depends on the specific antibody used. In the example shown here, lysosomes are immunostained with mouse anti-LAMP1 antibodies using a dilution of 1:500.
   2. The following day, wash the spheroids 5 times with 70 µL of PBS for 3 min each time.
   3. Dilute the secondary antibody at a dilution of 1:500, fluorescently-conjugated phalloidin at 1:500, and Hoechst 33342 (from a 1 mg mL^-1 stock) at 1:5000 in the antibody incubation buffer and add 70 µL to each well. Incubate overnight.
      NOTE: The antibody dilution depends on the specific antibody used. Highly cross-adsorbed secondary antibodies that show high photostability and high brightness are recommended.
   4. The following day, wash the spheroids 5 times with 70 µL of PBS for 3 min each time.
      ​NOTE: Plates can be stored for up to two weeks at RT prior to imaging, as long as the spheroids remain covered with PBS.

4. Image acquisition and analysis of spheroids

1. Image acquisition
   1. Insert the 96-well plate containing spheroids into a confocal high-content screening microscope.
   2. Select the appropriate lasers to excite the fluorophores used.
   3. Acquire the channels sequentially to avoid cross-talk.
   4. Image the spheroids using appropriate objectives.
      NOTE: The use of water immersion objectives is recommended if available. For example, a 20x/1.0 NA objective can image an entire well in ~77 fields of view. A 63x/1.15 NA objective can image an entire well in approximately 826 fields of view.
   5. Image ~30-40 slices, depending on the depth of the spheroid, with each slice taken at an interval of 1.5 µm from the preceding one.
2. Image analysis
   1. For morphological analysis of spheroids, follow steps 4.2.2-4.2.6.
   2. Segment the spheroids based on the fluorescently-conjugated phalloidin staining.
   3. Segment the nuclei based on the Hoechst 33342 staining.
   4. Segment the cytoplasm of each cell by the residual Hoechst 33342 stain that is present in the cell cytoplasm.
   5. Calculate different morphological properties of the spheroids, including volume, surface area, sphericity, and the number of nuclei per spheroid.
      NOTE: This information is extracted using various algorithms that are in-built in the image analysis software of choice.
   6. Process images further to remove spheroids smaller than 75,000 µm³ and larger than 900,000 µm³.
      NOTE: These values are suggestions to allow the removal of very small cell assemblies and large assemblies that may have arisen as a result of the fusion of multiple spheroids. Spheroids can also be categorized into different size classes at this step.
   7. To analyze single cells within spheroids, follow steps 4.2.8-4.2.12.
   8. Segment the spheroids based on the fluorescently-conjugated phalloidin staining.
   9. Segment the nuclei based on the Hoechst 33342 staining.
   10. Segment the cytoplasm of each cell by the residual Hoechst 33342 stain that is present in the cell cytoplasm.
   11. Segment the lysosomes based on the secondary antibody staining.
   12. Calculate different morphological properties of the cells within each spheroid, including the number of lysosomes per cell, cell volume, and cell surface area.
       NOTE: This information is extracted using various algorithms that are in-built in the image analysis software of choice.

Results

In this protocol, a robust method to produce 3D cell culture assemblies in the form of spheroids, using different cell types to represent various tumor tissues, is detailed. This method allows for the generation of hundreds of spheroids per well, which enables cell-based assays to be performed in a high-content manner (Figure 1). This approach has previously been used to study nanoparticle uptake in HT-29 spheroids¹⁶ and nanoparticle-induced toxicity in HepG2 spheroid...

Discussion

The approach described here details a platform for generating several hundred spheroids per well in a manner that is suitable for HCS and HCA. In comparison to other popular methods, such as the use of flat-bottomed and round-bottomed ULA plates, which allow the formation of only one spheroid per well^18,19, this method provides the opportunity for high-resolution information to be extracted from large numbers of spheroids in a screening format. Notably, this meth...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
0.05% Trypsin-EDTA (1x), phenol red	Gibco	25300054
Bovine Serum Albumin (BSA)	Sigma Aldrich	A6003
Calcium chloride	Fisher Scientific	10050070
CellCarrier-96 Ultra Microplates, tissue culture treated, black, 96-well with lid	Perkin Elmer	6055302	These plates have been renamed as Phenoplates
Dimethyl sulfoxide (DMSO)	Sigma Aldrich	D2650
Foetal Bovine Serum (FBS), qualified, EU approved, South America origin, heat inactivated	Gibco	10500064
Glycine	Fisher Scientific	BP381-1
Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488	Invitrogen	A-11029
L-Glutamine solution, 200 mM	Gibco	25030024
Hoechst 33342	Sigma Aldrich	14533
Magnesium chloride	Fisher Scientific	10647032
Matrigel Basement Membrane Matrix, Phenol Red-free, LDEV-free, 10 mL	Corning	356237	This Matrigel formulation can be also found with the same catalogue number at BD Biosciences
Matrigel Growth Factor Reduced Matrigel	BD Biosciences	356231	This Matrigel formulation can be also found with the same catalogue number at Corning
McCoy's 5A medium	Gibco	26600023
McCoy's 5A medium with L glutamine and sodium bicarbonate, without phenol red	Hyclone	10358633
Minimum Essential Medium (MEM)	Gibco	21090022
Minimum Essential Medium (MEM), without glutamine, without phenol red	Gibco	51200046
Mouse monoclonal anti-LAMP1 antibody (concentrate)	Developmental Studies Hybridoma Bank	H4A3-a
Neubauer counting chamber	Hirschmann	8100203
Nunclon tissue culture dish with lid, polystyrene, 92 mm x 17 mm	ThermoFisher Scientific	150350
Opera Phenix HCS System and Harmony HCA software	Perkin Elmer	HCSHH14000000
Paraformaldehyde (PFA)	Sigma Aldrich	P6148
Phalloidin Alexa Fluor 568	Invitrogen	A12380
Phosphate Buffered Saline (PBS) tablets	Sigma Aldrich	P4417
Polysorbate 20	Sigma Aldrich	P5927
RPMI 1640 Medium, GlutaMAX Supplement	Gibco	61870010
RPMI 1640 Medium, without glutamine, without phenol red	Gibco	11835063
Triton X-100	Sigma Aldrich	T9284
Stericup sterile vacuum filter units	Millipore	SCGVU05RE